Drug Index


Mechanism :

Mitochondria-targeting peptide; free radical scavenger and antioxidant that penetrates the cellular and outer mitochondrial membranes, and targets cardiolipin, which is found exclusively in the inner mitochondrial membrane.

Indication :

  • Pending FDA approval
  • Mitochondrial Myopathies
  • Optic Neuropathy
  • Leber’s Hereditary Optic Neuropathy

Dosing :

Only for use in children >16 years of age.
0.01-0.25 mg/kg/h IV infusion over 2 hours for 5 days.

Adverse Effect :

Headache, dizziness, abdominal pain, flatulence.

Hepatic Dose :

No data available regarding dosage adjustment.
02/14/2024 22:10:40 Elamipretide
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0